Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Euroscreen SA Curated by ChEMBL | Assay Description Binding affinity to human recombinant NK3R by radioligand binding assay | ACS Med Chem Lett 6: 736-40 (2015) Article DOI: 10.1021/acsmedchemlett.5b00117 BindingDB Entry DOI: 10.7270/Q2TQ639V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | 60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2348QHC | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | 60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10836768 (2020) BindingDB Entry DOI: 10.7270/Q2Z03C74 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | 60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
BioCryst Pharmaceuticals | Assay Description Human NK-3: The ability of compounds of the invention to inhibit the binding of the NK-3 receptor selective antagonist 3H-SB222200 was assessed by an... | Bioorg Med Chem 17: 3934-58 (2009) BindingDB Entry DOI: 10.7270/Q2SN0C9W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | 60 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
EUROSCREEN SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US9422299 (2016) BindingDB Entry DOI: 10.7270/Q2GM866C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | 60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2348QHC | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | 60 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Rattus norvegicus) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 573 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Euroscreen SA Curated by ChEMBL | Assay Description Binding affinity to rat NK3R | ACS Med Chem Lett 6: 736-40 (2015) Article DOI: 10.1021/acsmedchemlett.5b00117 BindingDB Entry DOI: 10.7270/Q2TQ639V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
Euroscreen SA Curated by ChEMBL | Assay Description Antagonist activity against human recombinant NK3R expressed in CHO cells by aequorin functional assay | ACS Med Chem Lett 6: 736-40 (2015) Article DOI: 10.1021/acsmedchemlett.5b00117 BindingDB Entry DOI: 10.7270/Q2TQ639V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 93 | n/a | n/a | n/a | n/a | n/a | n/a |
Ogeda SA US Patent | Assay Description Changes in intracellular calcium levels are a recognized indicator of G protein-coupled receptor activity. The efficacy of compounds of the invention... | US Patent US10836768 (2020) BindingDB Entry DOI: 10.7270/Q2Z03C74 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 93 | n/a | n/a | n/a | n/a | n/a | n/a |
EUROSCREEN SA US Patent | Assay Description Chinese Hamster Ovary recombinant cells expressing the human NK-3 receptor and a construct that encodes the photoprotein apoaequorin were used for th... | US Patent US9422299 (2016) BindingDB Entry DOI: 10.7270/Q2GM866C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 93 | n/a | n/a | n/a | n/a | n/a | n/a |
OGEDA SA US Patent | Assay Description Changes in intracellular calcium levels are a recognized indicator of G protein-coupled receptor activity. The efficacy of compounds of the invention... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair |